OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Help
Advanced
Search
16
Results
Show all
Save search
Copy query
Show results for
Unknown
(16)
Publication Date
Release Date
2024
(5)
2025
(2)
2023
(2)
2016
(2)
2015
(2)
2026
(1)
2018
(1)
2017
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
Arterial Blood, Rather Than Venous Blood, is a Better Source for Circulating Melanoma Cells.
Not available
S-EPMC4740300
|
biostudies-literature
Cite
Establishment and Characterization of Orthotopic Mouse Models for Human Uveal Melanoma Hepatic Colonization.
Not available
S-EPMC4715216
|
biostudies-literature
Cite
Phase I study of evofosfamide, an investigational hypoxia-activated prodrug, in patients with advanced leukemia.
Not available
S-EPMC4946992
|
biostudies-literature
Cite
Initiating angiotensin II at lower vasopressor doses in vasodilatory shock: an exploratory post-hoc analysis of the ATHOS-3 clinical trial.
Not available
S-EPMC10163684
|
biostudies-literature
Cite
Retrotransposons Are the Major Contributors to the Expansion of the
Drosophila ananassae
Muller F Element.
Not available
S-EPMC5555453
|
biostudies-literature
Cite
The impact of low-mode symmetry on inertial fusion energy output in the burning plasma state.
Not available
S-EPMC10998902
|
biostudies-literature
Cite
Drosophila muller f elements maintain a distinct set of genomic properties over 40 million years of evolution.
Not available
S-EPMC4426361
|
biostudies-literature
Cite
Long-Term Effects of Empagliflozin in Patients with Chronic Kidney Disease.
Not available
S-EPMC7616743
|
biostudies-literature
Cite
Effects of empagliflozin on quality of life and healthcare use and costs in chronic kidney disease: a health economic analysis of the EMPA-KIDNEY trial.
Not available
S-EPMC12274867
|
biostudies-literature
Cite
Frailty, Multimorbidity, and Polypharmacy: Exploratory Analyses of the Effects of Empagliflozin from the EMPA-KIDNEY Trial.
Not available
S-EPMC11390031
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets